Sign in and upgrade to a paid plan to export futures history as CSV.

Clinitech Laboratory Limited

Healthcare · Healthcare Services

BSE: 544220
₹35.10
▼ -1.50 (-4.10%)
Sept. 1, 2026 · BSE · bse_bhavcopy

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-2 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
6.50
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 3 met
  • No Quality score is Strong (70 or more)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Value and momentum

0 of 1 met
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.1%
Low 35.1000 · High 35.1000
1W return
-1.1%
Low 35.0000 · High 36.6000
1M return
Data unavailable.
Low 35.0000 · High 38.5000
52W return
Data unavailable.
Low 35.0000 · High 38.5000
Lifetime High ₹38.5000 (Aug. 17, 2026)
Lifetime Low ₹35.0000 (Aug. 27, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish1
5D
36.0

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
97.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

35.10
Pivot
First resistance35.10
Second resistance35.10
Third resistance35.10
First support35.10
Second support35.10
Third support35.10
Day RSI—
Day MFI—
Day MACD—
Day MACD signal—

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

—
Over 1 Month
LowHigh
35.0038.50
—
Over 3 Months
LowHigh
35.0038.50
—
Over 6 Months
LowHigh
35.0038.50
—
Over 1 Year
LowHigh
35.0038.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter64.20%
  • FII/FPI0.32%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 62.42% to 64.20% in Mar 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.32% in Mar 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
16 Apr 2026 VORTON OPPORTUNITIES FUND Bulk Buy 14,400 44.5200 BSE
23 Mar 2026 BINABEN BIPINKUMAR MEHTA Bulk Sell 12,000 33.2000 BSE
23 Mar 2026 SIDDHARTH BIPINBHAI MEHTA Bulk Buy 12,000 33.2000 BSE
23 Mar 2026 MUKESH KESHUBHAI THUMAR Bulk Sell 16,800 32.9500 BSE
17 Mar 2026 SANJAY HARSHADRAI MEHTA Bulk Sell 18,000 33.3400 BSE
29 Jan 2026 RAHUL R MAHAJAN Bulk Sell 12,000 29.5400 BSE
29 Jan 2026 SANJAY HARSHADRAI MEHTA Bulk Buy 15,600 32.3200 BSE
17 Nov 2025 BINABEN BIPINKUMAR MEHTA Bulk Buy 13,200 40.1500 BSE
19 Aug 2025 BONANZA PORTFOLIO LIMITED Bulk Sell 3,600 52.9700 BSE
19 Aug 2025 KRIPANANDA CHIDAMBARAM Bulk Sell 15,600 52.9700 BSE

All bulk and block deals →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Clinitech Laboratory Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.